Arbutus Biopharma Corp. (ABUS)

4.70 +0.11 (+2.40%) USD  |  NASDAQ  |  Dec 11, 13:37
More

Arbutus Biopharma Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for ABUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
Boston Scientific Corp. Upgrade
Trevi Therapeutics, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade
Palatin Technologies, Inc. Upgrade
Theriva Biologics, Inc. Upgrade

Return on Net Operating Assets Related Metrics

Return on Equity Upgrade
Return on Assets Upgrade
Return on Invested Capital Upgrade
Profit Margin (Quarterly) Upgrade
Gross Profit Margin (Quarterly) Upgrade
Operating Margin (Quarterly) Upgrade